Artificial intelligence (AI) is a tool that has proven useful in many fields, from machine learning, to, natural language ...

Profound Medical Corp., a commercial-stage medical device company that develops and markets customizable, incision-free ...

Recognizing TULSA is being used by urologists to treat an unrivalled variety of prostate cancer and/or BPH patients, Profound is developing a novel set of software modules under the TULSA-AI ® brand ...

MDxHealth to Participate in Piper Sandler Healthcare Conference IRVINE, CA – November 25, 2024 (GlobeNewswire) – MDxHealth SA (NASDAQ: MDXH) (the "Company" or "mdxhealth"), a leading precision ...

Prostate cancer is the second most commonly diagnosed cancer in men (behind skin cancer), with varying levels of ...

and the 25th Annual Meeting of the Society of Urologic Oncology taking place in Dallas, TX, December 4 – 6, 2024. The TULSA procedure, performed using Profound’s TULSA-PRO system, has the potential of ...

Algert Global LLC boosted its stake in shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT – Free Report) by 41.4% in the 3rd ...

Valley Health System says the new West Henderson Hospital will open Dec. 3 with 150 beds but has been master planned to ...

In “Lee v Westchester Medical Center,” a second-year radiologist and first-year resident neurologist at Westchester Medical ...

Massachusetts Financial Services Co. MA decreased its holdings in PROCEPT BioRobotics Co. (NASDAQ:PRCT – Free Report) by 8.1% ...

Cancer care is incredibly costly for many patients, and treatment costs are not the only financial consideration. According ...

Treatment with UGN-102 in patients with recurrent low-grade intermediate-risk non-muscle-invasive bladder cancer demonstrated ...